relmada.com (RLMD) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Relmada Therapeutics (RLMD) biznesi esometoDoubleton patentiga tayanadi, garchi avvalgi testlarning tebranishlari spekulyativ xavfni yuzaga keltirsa-da. Kompaniya REL-1017 dorisining sinovlarini kengaytirish orqali neyrofarmatsevtika bozorini egallashni maqsad qilgan. Psixiatriyaga NMDA retseptorlarini bloklovchilarning kirib kelishi ruhiy salomatlik uchun yangi standartni belgilamoqda. Uzoq muddatli majburiyatlarning kapitalga nisbati moliyaviy leverajni namoyish etadi, bunda 0.00 ko'rsatkichi ushbu metrikaning holatini ifodalaydi.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_RLMD_-_Relmada-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "RLMD - Relmada Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 29.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Relmada Therapeutics kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati relmada.com|RLMD - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Relmada Therapeutics, Inc.|RLMD - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzi Relmada Therapeutics
Kompaniyaning jamlanma tahlili:RLMD (Relmada Therapeutics Inc)
Relmada Therapeutics (RLMD) kompaniyasidagi rivojlanish ko'lami uzoq muddatli moliyaviy qaramlik koeffitsiyenti dinamikasida aks etgan. Ushbu metrika bir yildan ortiq muddatga ega majburiyatlarni umumiy kapital bilan solishtirish orqali biznesning barqarorligini baholaydi. 0.00 ning hisoblangan qiymati qarz yuklamasining joriy darajasini ko'rsatadi. Past leveraj kompaniyaga kreditlar o'rniga kapital rag'batlantirish vositalaridan foydalangan holda, nevrologlarning elita shtatiga investitsiya kiritish imkonini beradi. Investorlar bunday balansni yuqori to'lov qobiliyatining belgisi sifatida talqin qiladilar.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|HRMY: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Praxis Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|ceribell.com (CBLL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Alector (ALEC) - Uzoq muddatli qarzning kapitalga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMER (Omeros Corp.)|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Tevogen Bio Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Cassava Sciences Inc SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzning kapitalga nisbati Ovid Therapeutics Inc OVID|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Clene (CLNN)|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|Uzoq muddatli qarzning kapitalga nisbati jupiterneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati ANVS (Annovis Bio)|Uzoq muddatli kreditlarning kapitalga nisbati GRCE|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|Uzoq muddatli qarzdorlikning kapitalga nisbati ANEW Medical (KLTO)|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|revivapharma.com (RVPH) - Uzoq muddatli qarzning o'z kapitaliga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|PASG: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzning o'z kapitaliga nisbati NERV (minervaneurosciences.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|CYCN (Cyclerion Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Avenue Therapeutics Inc. ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzning o'z kapitaliga nisbati TRVN (Trevena Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati